What is rheumatoid arthritis? Considering consequences of changed classification criteria.

Item

http://www.wikidata.org/entity/Q52847474

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

What is rheumatoid arthritis? ...... anged classification criteria.

@en

What is rheumatoid arthritis? ...... anged classification criteria.

@nl

type

Item

label

What is rheumatoid arthritis? ...... anged classification criteria.

@en

What is rheumatoid arthritis? ...... anged classification criteria.

@nl

prefLabel

What is rheumatoid arthritis? ...... anged classification criteria.

@en

What is rheumatoid arthritis? ...... anged classification criteria.

@nl

P1476

What is rheumatoid arthritis? ...... anged classification criteria.

@en

P2093

Angela Zink

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.

The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.

Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis

What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review.

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review.

P304

315-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/ANNRHEUMDIS-2016-209629

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Annette van der Helm-van Mil

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27658679

http://www.w3.org/2001/XMLSchema#string